Literature DB >> 11755477

The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype.

Tomoko Nakagami1, Qing Qiao, Jaakko Tuomilehto, Beverley Balkau, Bendix Carstensen, Naoko Tajima, Yasuhiko Iwamoto, Knut Borch-Johnsen, Knut Borch-Jonsen.   

Abstract

To assess the use of fasting plasma glucose (FPG) alone for the screening of diabetes as defined by a 2-h plasma glucose (2-h PG) > or =11.1 mmol/l following a 75-g oral glucose tolerance test, we collated the results from 17512 subjects aged 30-89 years without a previous history of diabetes from 12 general population-based Asian studies. The performance of FPG corresponding to the 2-h PG > or =11.1 mmol/l was characterized. The prevalence of diabetes was 4.0% by the FPG criteria only and 6.0% by the 2-h PG criteria only. The FPG value of 7.0 mmol/l gave a sensitivity for diabetes as defined by a 2-h PG > or =11.1 mmol/l of 46% and specificity of 99%. The FPG associated with a 2-h PG > or =11.1 mmol/l with optimal sensitivity and specificity was 5.8 mmol/l (sensitivity 79%, specificity 85%). The optimal FPG cut-point was affected by gender, age, body mass index and the presence of hypertension, and the resulting sensitivity and specificity corresponding to each optimal cut-point changed. The FPG was a specific but insensitive screening test for diabetes defined by 2-h PG > or =11.1 mmol/l. There seems to be ethnic differences with respect to optimal FPG cut-point, and different screening strategies may be necessary in different parts of the world.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755477     DOI: 10.1016/s0168-8227(01)00270-4

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin.

Authors:  T Nakagami
Journal:  Diabetologia       Date:  2004-02-18       Impact factor: 10.122

2.  Specific changes of somatostatin mRNA expression in the frontal cortex and hippocampus of diabetic rats.

Authors:  Zhang XiaoMing; Zhu Xi; Shen Fang; Zhou Jilin
Journal:  J Anat       Date:  2004-03       Impact factor: 2.610

3.  Optimal cut-off points for two-step strategy in screening of undiagnosed diabetes: a population-based study in China.

Authors:  Zhen Ye; Liming Cong; Gangqiang Ding; Min Yu; Xinwei Zhang; Ruying Hu; Jianjun Wu; Le Fang; Hao Wang; Jie Zhang; Qingfang He; Danting Su; Ming Zhao; Lixin Wang; Weiwei Gong; Yuanyuan Xiao; Mingbin Liang; Jin Pan
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

4.  Dichotomy in the Impact of Elevated Maternal Glucose Levels on Neonatal Epigenome.

Authors:  Ives Yubin Lim; Xinyi Lin; Ai Ling Teh; Yonghui Wu; Li Chen; Menglan He; Shiao-Yng Chan; Julia L MacIsaac; Jerry K Y Chan; Kok Hian Tan; Mary Foong Fong Chong; Michael S Kobor; Keith M Godfrey; Michael J Meaney; Yung Seng Lee; Johan G Eriksson; Peter D Gluckman; Yap Seng Chong; Neerja Karnani
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

5.  Diagnostic accuracy of tests for type 2 diabetes and prediabetes: A systematic review and meta-analysis.

Authors:  Gunjeet Kaur; P V M Lakshmi; Ashu Rastogi; Anil Bhansali; Sanjay Jain; Yot Teerawattananon; Henna Bano; Shankar Prinja
Journal:  PLoS One       Date:  2020-11-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.